The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global infection surveillance solutions market was valued at US$ 580.9 Million in 2022.
We expect the global infection surveillance solutions market to exhibit a CAGR of 12.1% during 2023-2028.
The rising prevalence of hospital-acquired infections (HAIs) due to poor hygienic conditions and
negligence by medical staff, is currently driving the global infection surveillance solutions market.
The sudden outbreak of the COVID-19 pandemic has led to rising demand for infection surveillance
solutions to analyze the spread of coronavirus infection and to offer accurate results, surgical database,
real-time medical records, etc.
Based on the component, the global infection surveillance solutions market can be segmented into
software and services. Currently, software holds the majority of the total market share.
Based on the deployment type, the global infection surveillance solutions market has been divided into
on-premises and cloud-based, where on-premises deployment currently exhibits a clear dominance in
Based on the end user, the global infection surveillance solutions market can be categorized into
hospitals, clinics, ambulatory service centers, specialty centers, and others. Among these, hospitals
currently account for the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global infection surveillance solutions market include Baxter
International Inc., Becton Dickinson and Company, Centrak Inc. (Halma plc), Cerner Corporation, CKM
Healthcare Incorporated, Ecolab Inc., International Business Machines Corporation, Medexter
Healthcare, Perahealth Inc., PointClickCare, Premier Inc., and Sunquest Information Systems Inc. (Roper
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at